HIGHLIGHTS
- who: Emilie Chipon from the REMEDEE LABS SA, Montbonnotu2011Saintu2011Martin, France have published the research: A drug free solution for improving the quality of life of fibromyalgia patients (Fibrepik): study protocol of a multicenter, randomized, controlled effectiveness trial, in the Journal: (JOURNAL)
- what: The effectiveness of the solution is evaluated according to the primary objective the improvement of the quality of life measured through the dedicated Fibromyalgia Impact Questionnaire after 3 months. The aim of this methodu2011 ology is to limit deception bias and facilitate inclusion. The authors of the study suggest that this assistance could . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.